We are live on ! Find out more
CAG

Csenge Advisory Group Portfolio holdings

AUM $2.18B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+16.73%
3 Year Est. Return
+51.88%
5 Year Est. Return
+54.25%
10 Year Est. Return
AUM
$1.49B
AUM Growth
+$106M
Cap. Flow
+$53.6M
Cap. Flow %
3.59%
Top 10 Hldgs %
31.12%
Holding
701
New
106
Increased
294
Reduced
232
Closed
43
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
201
Intel
INTC
$466B
$1.09M 0.07%
32,743
+3,583
+12% +$112K
ASML icon
202
ASML
ASML
$675B
$1.07M 0.07%
1,480
+349
+31% +$237K
PNOV icon
203
Innovator US Equity Power Buffer ETF November
PNOV
$879M
$1.07M 0.07%
31,622
-1,000
-3% -$32.5K
PCEF icon
204
Invesco CEF Income Composite ETF
PCEF
$812M
$1.07M 0.07%
58,924
-10,448
-15% -$187K
VBR icon
205
Vanguard Small-Cap Value ETF
VBR
$37.1B
$1.06M 0.07%
6,382
+152
+2% +$23.9K
AFL icon
206
Aflac
AFL
$63.9B
$1.05M 0.07%
15,076
+1,174
+8% +$78.6K
TLH icon
207
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
$1.05M 0.07%
9,483
-151
-2% -$16.9K
MPT
208
Medical Properties Trust
MPT
$2.89B
$1.05M 0.07%
113,177
+93,754
+483% +$793K
SCHM icon
209
Schwab US Mid-Cap ETF
SCHM
$14.6B
$1.02M 0.07%
43,209
+3,543
+9% +$79.8K
HIG icon
210
Hartford Financial Services
HIG
$38.5B
$1.01M 0.07%
14,065
-97
-0.7% -$6.81K
VTEB icon
211
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$1.01M 0.07%
20,149
-4,443
-18% -$223K
SYK icon
212
Stryker
SYK
$127B
$1.01M 0.07%
3,307
+307
+10% +$88.7K
CB icon
213
Chubb
CB
$140B
$1,000K 0.07%
5,191
-745
-13% -$146K
VHT icon
214
Vanguard Health Care ETF
VHT
$18.2B
$999K 0.07%
+4,079
New +$992K
ORCL icon
215
Oracle
ORCL
$331B
$987K 0.07%
8,292
+1,504
+22% +$156K
SCHA icon
216
Schwab U.S Small- Cap ETF
SCHA
$22.5B
$986K 0.07%
45,038
+3,272
+8% +$68.2K
GILD icon
217
Gilead Sciences
GILD
$161B
$971K 0.07%
12,597
+1,674
+15% +$134K
OMC icon
218
Omnicom Group
OMC
$22.7B
$960K 0.06%
10,090
-157
-2% -$14.6K
SHY icon
219
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$960K 0.06%
11,836
-37,082
-76% -$3.03M
TJX icon
220
TJX Companies
TJX
$170B
$951K 0.06%
11,215
-1,143
-9% -$90.2K
QCOM icon
221
Qualcomm
QCOM
$176B
$950K 0.06%
7,984
-246
-3% -$28.3K
IUSG icon
222
iShares Core S&P US Growth ETF
IUSG
$31.1B
$950K 0.06%
9,726
+3,598
+59% +$330K
CVS icon
223
CVS Health
CVS
$137B
$948K 0.06%
13,710
-805
-6% -$57.3K
VSS icon
224
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$945K 0.06%
8,549
+2,555
+43% +$282K
CMI icon
225
Cummins
CMI
$91.7B
$943K 0.06%
3,848
-196
-5% -$44.4K

Similar funds

Csenge Advisory Group's Q2 2023 Portfolio in Review

As of Q2 2023, Csenge Advisory Group held 701 positions worth $1.49B, up 7.7% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Csenge Advisory Group deployed $53.6M of net new capital in Q2 2023, opening 106 new positions and adding to 294 existing holdings. Its largest new stake was First Trust Limited Duration Investment Grade Corporate ETF: 1,165,577 shares worth $21.7M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.3% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was First Trust Senior Loan Fund ETF, an estimated $16.5M trimmed.

  • Csenge Advisory Group's largest Q2 2023 buy was First Trust Limited Duration Investment Grade Corporate ETF: 1,165,577 shares worth $21.7M.
  • Csenge Advisory Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2023, an estimated $18.9M increase.
  • Csenge Advisory Group's biggest Q2 2023 reduction was First Trust Senior Loan Fund ETF, cutting an estimated $16.5M.
  • Csenge Advisory Group fully exited First Trust NASDAQ ABA Community Bank Index Fund in Q2 2023, selling an estimated $4.95M.
  • Csenge Advisory Group's ten largest holdings make up 31% of its $1.49B portfolio in Q2 2023.
  • Csenge Advisory Group opened 106 new positions and closed 43 in Q2 2023.
  • Csenge Advisory Group's portfolio value rose 7.7% quarter-over-quarter to $1.49B.

Based on Csenge Advisory Group's 13F filing for Q2 2023, filed 20 Jul 2023.